Article information
Full text is only aviable in PDF
Bibliografia
[1.]
J.S. Schwartz.
Pneumococcal vaccine: clinical efficacy and efectiveness.
Ann Intern Med, 96 (1982), pp. 208-220
[2.]
R. Austrian, J. Gold.
Pneumococcal bacteriemia with special reference to bacteremic pneumococcal pneumonía.
Ann Intern Med, 60 (1964), pp. 759-776
[3.]
M.A. Mufson, D.M. Kruss, R.E. Wasil, W.I. Metzger.
Capsular types and outcome of bacteremic pneumococcal pneumonía.
Ann Intern Med, 143 (1974), pp. 505-510
[4.]
R. Austrian.
A reassessment of pneumococcal vaccine.
N Engl J Med, 303 (1980), pp. 549-552
[5.]
Centers for Disease Control Update: pneumococcal polysaccharide vaccine usage. United States.
MMWR, 33 (1984), pp. 273-276
[6.]
Health and Public Policy Committee American College of Physicians. Pneumococcal vaccine.
Ann Intern Med, 104 (1986), pp. 118-120
[7.]
C.V. Broome, R.R. Facklam.
Epidemiology of clinically significant isolates of Streptococcus pneumoniae in the United States.
Rev Infect Dis, 3 (1981), pp. 277-281
[8.]
J. Weisholtz, B.J. Hartman, R.B. Roberts.
Effect of underlying disease and age on pneumococcal serotype distribution.
Am J Med, 75 (1983), pp. 199-205
[9.]
Ausina V. Datos personales no publicados 1986
[10.]
G. Bolan, C.V. Broome, R.R. Facklam, B.D. Plikaytus, D.W. Fraser, Schlech WFIII.
Pneumococcal vaccine efficacy in selected populations in the United States.
Ann Intern Med, 104 (1986), pp. 1-6
[11.]
J.H. Williams Jr., K.M. Moser.
Pneumococcal vaccine and patients with chronic lung disease.
Ann Intern Med, 104 (1986), pp. 106-109
[12.]
J.E. Sisk, R.K. Riegelman.
Cost effectiveness of vaccination against pneumococcal pneumonia: an update.
Ann Intern Med, 104 (1986), pp. 79-86
[13.]
F.M. La Force, T.C. Eickhoff.
Pneumococcal vaccine: the evidence mounts.
Ann Intern Med, 104 (1986), pp. 110-112
[14.]
C.V. Broome, R.R. Facklam, D.W. Fraser.
Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine.
N Engl J Med, 303 (1980), pp. 544-552
[15.]
M.A. Mufson, G. Oley, D. Hughey.
Pneumococcal disease in a medium-sized community in the United States.
JAMA, 248 (1982), pp. 1486-1489
[16.]
J.T. MacFarlane, R.G. Finch, M.J. Ward, A.D. Macrae.
Hospital study of adult community-acquired pneumonia.
Lancet, 2 (1982), pp. 255-258
[17.]
E.D. Shapiro, J.D. Clemens.
A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections.
Ann Intern Med, 101 (1984), pp. 325-336
[18.]
G.R. Siber, S.A. Witzman, A.C. Aisenberg.
Antibody response of patients with Hodgkin's disease to protein and polysaccharide antigens.
Rev Infect Dis, 3 (1981), pp. S144-S159
[19.]
H.M. Foy, B. Wentworth, G.E. Kenny, J.M. Kloeck, J.T. Grayston.
Pneumococcal isolations from patients with pneumonia and control subjects in a prepaid medical care group.
Am Rev Respir Dis, 3 (1975), pp. 595-603
[20.]
D.S. Fedson.
Hospital care and pneumococcal immunisation policy.
Lancet, 2 (1982), pp. 1226-1227
[21.]
M. Woodhead, J.T. MacFarlane.
Prevención de la neumonía neumocócica.
Lancet (ed. cast.), 3 (1983), pp. 116
Copyright © 1987. Sociedad Española de Neumología y Cirugía Torácica
